Skip to main content

Table 2 The expression of VSTM1-v1 at various stages of myelocytic differentiation

From: VSTM-v1, a potential myeloid differentiation antigen that is downregulated in bone marrow cells from myeloid leukemia patients

 

Myeloblasts

Promyelocytes

Myelocytes

Metamyelocytes

CD markers

CD34+

CD34, CD117+, CD16

CD34, CD117, CD16, CD13+

CD16+

VSTM1-v1-positive cells (%)

5.69 ± 2.69

11.48 ± 4.58

35.02 ± 11.58

61.63 ± 8.53

P valuea

<0.001

<0.001

<0.001

 
  1. aThe P value was calculated using a Wilcoxon signed ranks test as compared with the next stage.